[对心脏门手术不同输血策略的随机对照临床试验的中期分析]
1Guangdong Cardiovascular Institute, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, Guangzhou 510080,China.
Zhonghua wai ke za zhi [Chinese journal of surgery]
|May 26, 2025
概括
这项研究发现,限制性和自由性红细胞输血策略在心脏门手术中的重大不良事件中没有显著差异. 然而,自由的策略可能会增加男性患者的风险.
科学领域:
- 心血管外科心血管外科
- 输血医学 输血医学
- 关键护理医学 关键护理医学
背景情况:
- 心脏门手术通常需要红细胞 (RBC) 输血.
- 输血策略旨在通过控制血红蛋白 (Hb) 和血红素 (Hct) 水平来优化患者的治疗结果.
- 在心脏门手术中最佳的红细胞输血策略仍在争论中.
研究的目的:
- 在接受心脏门手术的患者中,比较限制性与自由性红细胞输血策略的临床有效性.
- 评估不同输血值对术后结果的影响.
主要方法:
- 一个前性,随机控制的优越性试验,涉及439名接受非紧急心脏门手术的患者.
- 患者被随机分配到限制性 (绕道时Hb ≤ 60 g/L或Hct ≤ 18%,术后Hb ≤ 70 g/L或Hct ≤ 21%) 或自由的 (绕道时Hb ≤ 80 g/L或Hct ≤ 24%,术后Hb ≤ 100 g/L或Hct ≤ 30%) 输血策略.
- 主要结局是3个月死亡率,感染,缺血事件和需要透析的新发功能衰竭的组合.
主要成果:
- 在限制性 (10.9%) 和自由 (9.6%) 组之间的初级复合结果中,没有发现统计学上显著的差异 (P>0.05).
- 输血率在限制性组 (19.0%) 与自由主义组 (100%) 相比显著较低 (P<0.01).
- 亚组分析表明,性别和输血策略之间存在潜在的相互作用,自由输血可能会增加男性的风险 (P=0.023).
结论:
- 中期结果表明,限制性红细胞输血策略在心脏门手术后减少术后不良事件方面并不优于自由的策略.
- 通过限制性策略,可以显著降低输血率.
- 可能需要进一步的研究来探索这种人群中输血策略对性别特异性的影响.
更多相关视频
相关概念视频
Aortic Regurgitation III: Medical Management
54
Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
54
Mitral Regurgitation III: Medical Management
36
Mitral regurgitation (MR) is characterized by retrograde blood circulation from the left ventricle into the left atrium due to inadequate mitral valve closure. The severity of the condition, symptoms, and underlying cause determine treatment strategies.Monitoring and Pharmacological TreatmentPatients with mild to moderate MR typically do not need immediate intervention but regular monitoring to assess progression and guide treatment. Patients with mild MR should have an echocardiogram every 3-5...
36
Mitral Stenosis III: Medical Management
31
Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
31
Heart Failure VI: Adjunct Therapies
40
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
40


